KOSDAQMachinery163280

Airrane

₩3,705▼ 4.51%2026-11-18 close
Market Cap
₩50.4B
Turnover
₩1B
Volume
260K
Shares out.
13.6M
PER
4.9×
PBR
—
EPS
₩781
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Airrane: Annual Profit Rising, Quarterly Earnings Volatile

Airrane's annual results improved from a 2023 loss to wider profit in 2025, but a third-quarter 2026 net loss attributable to controlling shareholders makes quarterly earnings stability the next test.

  1. 1

    Annual sales rose from KRW 16.3 billion in 2023 to KRW 28.1 billion in 2025, and the operating margin climbed from 1.5% to 11.0% over the same period.

  2. 2

    Sales grew in the second and third quarters of 2026, while operating profit fell for two straight quarters after peaking in the first quarter of 2026.

  3. 3

    The third quarter of 2026 swung to a net loss attributable to controlling shareholders of KRW 1.77 billion, exposing a gap between operating profit and bottom-line results.

  4. 4

    A roughly KRW 1.4 billion biogas upgrading contract in the Paju mini hydrogen city project (June 2026) and the Cheongju new plant, expected to lift capacity by about 20%, are the main growth variables.

  5. 5

    Nitrogen generation made up 74.2% of sales on a cumulative basis through the third quarter of 2025, so the mix is concentrated in one application and overseas revenue swings flow directly into results.

02

Business structure

Airrane develops, manufactures and sells gas separation membranes built from polymer hollow fibers. The company was founded in 2001 and listed on KOSDAQ in 2024. A membrane module passes a mixed gas through hundreds of thousands of hollow fibers, each roughly as thick as a human hair, to separate the target gas.

Its main applications are nitrogen generation, biogas upgrading, CO2 capture and hydrogen production and purification, and it supplies modules and systems to customers in oil and gas, energy, biogas and petrochemicals.

On a cumulative basis through the third quarter of 2025, nitrogen accounted for 74.2% of sales by application, CO2 capture for 19.5%, biogas upgrading for 2.3% and other uses for 4.0% (a January 2026 equity research report).

Nitrogen is described as a steady grower because replacement demand keeps accumulating, while biogas and CO2 businesses were cited as drivers of sales growth in 2026.

In June 2026 Airrane announced a biogas upgrading contract worth about KRW 1.4 billion in the Paju mini hydrogen city project, with work running through July 31, 2027.

Overseas, the company has project records in China, Brazil and Malaysia, and in a November 10, 2026 announcement it said it is pursuing new biogas upgrading orders with European plant operators. The company says it was the seventh firm worldwide to commercialize gas separation membranes.

Because revenue from China and Europe feeds directly into reported results, shifts in regional demand and trade conditions show up quickly in the numbers.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩6B₩500M8.1%
2025Q4₩7.2B₩300M4.8%
2026Q1₩6.3B₩1.2B18.3%
2026Q2₩7.6B₩800M10.8%
2026Q3₩9.4B₩800M8.5%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2023₩16.3B₩200M-₩15.1B1.5%−44.2%32.7%
2024₩24.5B₩1.9B₩2B7.6%3.1%28.8%
2025₩28.1B₩3.1B₩2.8B11.0%4.1%61.7%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-18

04

Earnings analysis

Annual sales rose from KRW 16.3 billion in 2023 to KRW 24.5 billion in 2024 (up 49.9% year on year) and KRW 28.1 billion in 2025 (up 14.6% year on year), growing for two consecutive years from 2024 to 2025, with 2025 the largest year of the 2023 to 2025 span.

Operating profit went from KRW 240 million in 2023 to KRW 1.87 billion in 2024 (up 679.4% year on year) and KRW 3.09 billion in 2025 (up 65.1% year on year), while the operating margin moved from 1.5% to 7.6% to 11.0%.

Net profit attributable to controlling shareholders swung from a net loss of KRW 15.1 billion in 2023 to a profit of KRW 1.98 billion in 2024, then reached KRW 2.8 billion in 2025 (up 41.7% year on year).

In 2023 the net loss of KRW 15.1 billion was far larger than operating profit of KRW 240 million, pointing to a heavy burden from items below operating profit.

The debt ratio rose to 61.7% at the end of 2025 from 28.8% in 2024, with total liabilities of KRW 42.5 billion and total equity of KRW 68.9 billion, all attributable to controlling shareholders. Operating cash flow was KRW 4.51 billion in 2023, -KRW 135 million in 2024 and KRW 1.78 billion in 2025.

Quarterly sales went from KRW 6.01 billion in the third quarter of 2025 to KRW 7.18 billion in the fourth quarter (up 19.5% quarter on quarter), dipped to KRW 6.34 billion in the first quarter of 2026 (down 11.8%), then rose to KRW 7.63 billion in the second quarter and KRW 9.36 billion in the third quarter (up 55.7% year on year), marking two straight quarters of growth.

Operating profit peaked at KRW 1.16 billion in the first quarter of 2026 (up 233.1% quarter on quarter), then fell for two straight quarters to KRW 825 million and KRW 796 million.

For the first half of 2026, the CEO attributed the drop in sales and operating profit to higher export logistics costs tied to the US-Iran conflict and to accounting timing changes in system sales, calling them temporary.

Net profit attributable to controlling shareholders rose to KRW 4.09 billion in the second quarter of 2026, but the third quarter swung to a net loss of KRW 1.77 billion, with a loss recorded in a quarter that earned KRW 796 million in operating profit, so below-the-line items were volatile.

Over the last four quarters, from the fourth quarter of 2025 through the third quarter of 2026, net profit attributable to controlling shareholders totaled KRW 5.31 billion.

05

Industry analysis

Carbon neutrality policy has pushed more companies to adopt carbon capture, utilization and storage (CCUS) technology, and a January 2026 equity research report described membrane-based capture equipment adoption as picking up.

Biogas upgrading ties into projects that turn organic waste into clean hydrogen feedstock, and municipal hydrogen infrastructure such as the Paju mini hydrogen city is adding to demand. A June 2025 Shinyoung Securities report carried a supply-demand table that assumes biogas-related demand rises sharply through 2030.

On the cycle, nitrogen generation equipment is in a phase of accumulating replacement demand, while CO2 capture and biogas upgrading produce quarterly results that depend on when projects are awarded.

In competition, the company highlights being the only domestic specialist in gas separation membranes and the seventh firm worldwide to commercialize the technology. Shinyoung Securities viewed the company's China sales positively in June 2025, noting they are free from tariff effects despite tariff uncertainty.

By contrast, European sales fell to KRW 710 million in 2024, down 77% year on year, after the company halted its Russian business. The company cited higher export logistics costs as a factor behind the first-half 2026 decline, which shows that global shipping conditions are a variable for the sector.

As a small, specialized operator, a single project can have a large effect on quarterly results, which is also worth weighing when reading the industry backdrop.

06

Outlook

In its first-quarter 2026 results announcement, the company said it expects new orders and gradual earnings improvement from the second half, supported by new products and expanded capacity (May 2026 report).

The Cheongju new plant began equipment transfer in April 2026, with full operation planned from mid-May, and the company expects capacity to rise about 20% once running. A next-generation module that improves separation efficiency and durability is planned for launch within 2026.

A January 2026 equity research report forecast 2026 sales of KRW 32.3 billion (up 16.6% year on year) and operating profit of KRW 4.3 billion (up 26.5% year on year), and the same report noted a plan to add up to 12 hollow fiber production lines by the end of 2026.

Full-year 2026 sales and operating profit will be confirmed in the 2026 annual report, due by the end of March 2027.

Based on a June 2025 Shinyoung Securities report, planned facility investment totals KRW 22.3 billion, split into KRW 9.44 billion for membrane module manufacturing equipment, KRW 6.3 billion for a CO2 liquefaction plant process, and KRW 6.56 billion for ionomer recovery and regeneration equipment, with execution scheduled from the first quarter of 2025 through the fourth quarter of 2026.

Overseas, the company is pursuing cooperation with European operators and new biogas upgrading orders, as announced in November 2026. The Paju project runs through July 31, 2027 and feeds into the biogas upgrading supply record.

The next checkpoint is how the new plant and new orders are reflected in sales from the fourth quarter of 2026 onward.

07

Valuation

PER
4.9×
PBR
—
ROE
7.5%
EPS
₩781
BPS
—
Dividend per share
₩0

A January 2026 equity research report said the multiple on 2026 estimated earnings was well above the average for small and mid-cap chemical companies with market capitalization under KRW 500 billion.

The company moved from a loss in 2023 to profit in 2024 and grew earnings after that, but a net loss in the third quarter of 2026 means the earnings picture over the last four quarters varies from one quarter to the next.

Net profit attributable to controlling shareholders totaled KRW 5.31 billion over the last four quarters, so a multiple read on quarterly earnings alone can differ widely.

Total equity at the end of 2025 was KRW 68.9 billion, all attributable to controlling shareholders, and the debt ratio rose to 61.7% in 2025 from 28.8% in 2024. The company does not appear to pay a dividend, so its dividend yield sits below the average for the KOSDAQ machinery and equipment sector.

The free share issue in March 2026, at one new share for each existing share, increased shares outstanding, so per-share comparisons with earlier periods have shifted. The largest shareholder and related parties held 21.7% after the treasury shares were canceled in December 2025, according to a January 2026 report.

The reference points for reading the multiple are full-year profit in the 2026 annual report and quarterly profit in the first-quarter 2027 report.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-18

08

Bull factors

Annual profitability improved

Operating profit grew from KRW 240 million in 2023 to KRW 3.09 billion in 2025, and the operating margin climbed from 1.5% to 11.0%. Net profit attributable to controlling shareholders turned positive in 2024 and rose again in 2025, moving the company from losses into profit. Operating cash flow also recovered from -KRW 135 million in 2024 to KRW 1.78 billion in 2025.

Order and product pipeline

A biogas upgrading supply contract worth about KRW 1.4 billion was secured for the Paju project in June 2026, and in November 2026 the company announced European cooperation and new order efforts. A next-generation module is planned for launch within 2026.

Sales rose for two consecutive quarters in the second and third quarters of 2026, pointing to a recovery in top-line momentum.

Capacity expansion and tariff-exposed China sales

The company expects capacity to rise about 20% when the Cheongju new plant is running. A January 2026 report noted a plan to add up to 12 hollow fiber production lines by the end of 2026. Shinyoung Securities viewed the company's China sales positively in June 2025, noting they are free from tariff effects.

09

Bear factors

Quarterly earnings volatility

The third quarter of 2026 swung to a net loss attributable to controlling shareholders of KRW 1.77 billion, and operating profit fell for two straight quarters from KRW 1.16 billion in the first quarter to KRW 796 million in the third.

A net loss in a quarter that earned KRW 796 million in operating profit shows that below-the-line items are volatile. Whether quarterly profit stabilizes will be visible in the first-quarter 2027 report.

Overseas revenue and external factors

European sales fell to KRW 710 million in 2024, down 77% year on year, after the Russian business was halted (Shinyoung Securities, June 2025). The company cited higher export logistics costs linked to the US-Iran conflict as a factor in the first-half 2026 decline. External variables such as tariffs and shipping costs can feed directly into sales.

Capital structure and financing

The debt ratio rose to 61.7% at the end of 2025 from 28.8% in 2024, with total liabilities of KRW 42.5 billion. In July 2026 the company announced a plan to cover about KRW 21.5 billion of accumulated deficit to improve its financial structure. Shinyoung Securities noted in June 2025 that additional fundraising for facility investment was possible.

10

Risk factors

Concentration in one application

Nitrogen generation accounted for 74.2% of sales on a cumulative basis through the third quarter of 2025, so demand changes in one application weigh heavily on results. Biogas upgrading (2.3%) and CO2 capture (19.5%) remain small, so how fast these businesses scale matters. Orders arrive project by project, which can make quarterly sales swing.

Capital and financial structure

Changes to the capital structure have continued, including the plan to cover accumulated deficit and the March 2026 free share issue. The debt ratio reached 61.7% at the end of 2025, and additional fundraising for facility investment has been flagged.

Operating cash flow recovered from -KRW 135 million in 2024 to KRW 1.78 billion in 2025, but that record is still short.

Overseas markets and trade conditions

Overseas sales in China and Europe affect reported results. European sales fell to KRW 710 million in 2024, and export logistics costs were cited as a drag in the first half of 2026. If overseas project records concentrate in a few regions, changes in local conditions have an outsized effect.

11

What to watch next

  1. End of December 2026

    Checks whether the next-generation module launch and the Cheongju capacity expansion translate into orders and sales. Also watch whether the up-to-12 hollow fiber line expansion targeted for year-end 2026 is completed.

  2. End of March 2027

    The 2026 annual report is due, showing whether full-year sales and operating profit match the quarterly trend. Also check how the gap between operating profit and net profit attributable to controlling shareholders seen in the third quarter of 2026 is reflected for the full year.

  3. Mid-May 2027

    The first-quarter 2027 report is due, to be compared with first-quarter 2026 sales of KRW 6.34 billion and operating profit of KRW 1.16 billion, to see whether profit has moved out of the two-quarter decline.

  4. End of July 2027

    The Paju biogas upgrading supply contract ends on July 31, 2027, so the sales recognition at completion and whether follow-on orders arrive are the points to watch.

12

Overall view

Airrane is the only domestic specialist in gas separation membranes, and its annual results improved after the 2023 loss, with sales rising from KRW 16.3 billion to KRW 28.1 billion and operating profit from KRW 240 million to KRW 3.09 billion through 2025.

Nitrogen generation is the core application, with biogas upgrading and CO2 capture cited as growth pillars.

Sales rose for two consecutive quarters in the second and third quarters of 2026, but operating profit fell for two straight quarters after peaking in the first quarter, and the third quarter swung to a net loss attributable to controlling shareholders of KRW 1.77 billion.

Positive factors include the Paju biogas order, the Cheongju plant start-up and the planned next-generation module, while negative factors include quarterly earnings volatility, overseas revenue swings, a rising debt ratio and the plan to cover accumulated deficit.

Net profit attributable to controlling shareholders totaled KRW 5.31 billion over the last four quarters, and whether quarterly profit follows the annual improvement trend is the next test.

The 2026 annual report, due by the end of March 2027, will confirm full-year results, and the first-quarter 2027 report will show the quarterly profit trend. This report is for information only and does not include a buy or sell opinion.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 17 more articles and sources
  1. thevc.kr
  2. calculator.io.kr
  3. comp.fnguide.com
  4. file.alphasquare.co.kr
  5. m.news.nate.com
  6. m.sedaily.com
  7. newswell.co.kr
  8. shinyoung.com
  9. news.nate.com
  10. investing.com
  11. digitaltoday.co.kr
  12. m.news.nate.com
  13. view.asiae.co.kr
  14. m.news.nate.com
  15. digitaltoday.co.kr
  16. newspim.com
  17. digitaltoday.co.kr

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis